Cart
sales@molnova.com
AG-13958
CAS No. 319460-94-1
AG-13958( AG-013958 )
Catalog No. M20778 CAS No. 319460-94-1
AG-13958 (AG-013958) a potent VEGFR tyrosine kinase inhibitor for the treatment of age-related macular degeneration.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 275 | In Stock |
|
| 5MG | 264 | In Stock |
|
| 10MG | 407 | In Stock |
|
| 25MG | 655 | In Stock |
|
| 50MG | 923 | In Stock |
|
| 100MG | 1228 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAG-13958
-
NoteResearch use only, not for human use.
-
Brief DescriptionAG-13958 (AG-013958) a potent VEGFR tyrosine kinase inhibitor for the treatment of age-related macular degeneration.
-
DescriptionAG-13958 (AG-013958) a potent VEGFR tyrosine kinase inhibitor for the treatment of age-related macular degeneration.
-
In Vitro——
-
In Vivo——
-
SynonymsAG-013958
-
PathwayAngiogenesis
-
TargetVEGFR
-
RecptorVEGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number319460-94-1
-
Formula Weight467.5
-
Molecular FormulaC26H22FN7O
-
Purity>98% (HPLC)
-
SolubilityDMSO:5 mg/mL (10.70 mM)
-
SMILESCc1cc(C(=O)Nc2cc(Nc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)ccc2F)n(C)n1
-
Chemical NameN-[2-Fluoro-5-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]amino]phenyl]-13-dimethyl-1H-pyrazole-5-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Barakat M R Kaiser P . VEGF inhibitors for the treatment of neovascular age-related macular degeneration[J]. Expert Opinion on Investigational Drugs 2009 18(5):637-646.
molnova catalog
related products
-
SAR131675
AR131675 is highly selective for VEGFR-3 versus 107 receptors, enzymes, ion channels, and 65 kinases.
-
PKI-166
PKI-166 is an oral inhibitor of EGF-R tyrosine kinase (IC50:0.7 nM) that is both effective and selective. PKI-166 can effectively inhibit the growth and metastasis of various human cancer cells including pancreatic cancer.
-
WAY-302159
WAY-302159 is a VEGFR2 inhibitor.
